Kei-Ichiro Inamori Selected Research

autosomal recessive Spastic paraplegia 26

9/2022

Functional validation of novel variants in B4GALNT1 associated with early-onset complex hereditary spastic paraplegia with impaired ganglioside synthesis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kei-Ichiro Inamori Research Topics

Disease

3	Insulin Resistance 01/2022 - 01/2018
2	Neoplasms (Cancer) 01/2019 - 04/2009
2	Inflammation (Inflammations) 01/2019 - 01/2018
2	Type 2 Diabetes Mellitus (MODY) 01/2018 - 01/2018
1	Hereditary Spastic Paraplegia 09/2022
1	Rare Diseases (Rare Disease) 09/2022
1	autosomal recessive Spastic paraplegia 26 09/2022
1	Obesity 01/2020
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2019
1	Cardiovascular Diseases (Cardiovascular Disease) 11/2018
1	Hypercholesterolemia 11/2018
1	Morbid Obesity 01/2018
1	Body Weight (Weight, Body) 01/2018
1	Immune System Diseases (Immune Disorders) 01/2018
1	Asthma (Bronchial Asthma) 01/2018
1	Dyslipidemias (Dyslipidemia) 01/2018
1	Neuromuscular Diseases (Neuromuscular Disease) 10/2014
1	Lung Neoplasms (Lung Cancer) 04/2009

Drug/Important Bio-Agent (IBA)

4	GangliosidesIBA 09/2022 - 01/2018
2	CholesterolIBA 01/2022 - 11/2018
2	LeptinIBA 01/2022 - 01/2018
2	Dystroglycans (Dystroglycan)IBA 10/2014 - 04/2009
1	G(M3) GangliosideIBA 01/2020
1	globotriaosylceramide (globotriosylceramide)IBA 01/2019
1	globotetraosylceramideIBA 01/2019
1	GlycosphingolipidsIBA 01/2019
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2019
1	Dietary CholesterolIBA 11/2018
1	Apolipoproteins E (ApoE)IBA 11/2018
1	Insulin ReceptorIBA 01/2018
1	Glucose (Dextrose)FDA LinkGeneric 01/2018
1	Insulin (Novolin)FDA Link 01/2018
1	haematoside synthetaseIBA 01/2018
1	A-factor (Streptomyces)IBA 04/2009
1	Laminin (Merosin)IBA 04/2009

Therapy/Procedure

1	Therapeutics 11/2018